| Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients DA Mitchell, KA Batich, MD Gunn, MN Huang, L Sanchez-Perez, SK Nair, ... Nature 519 (7543), 366-369, 2015 | 567 | 2015 |
| Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum LW Jones, KS Courneya, JR Mackey, HB Muss, EN Pituskin, JM Scott, ... Journal of clinical oncology 30 (20), 2530-2537, 2012 | 494 | 2012 |
| Unmet spiritual care needs impact emotional and spiritual well-being in advanced cancer patients MJ Pearce, AD Coan, JE Herndon, HG Koenig, AP Abernethy Supportive Care in Cancer 20, 2269-2276, 2012 | 397 | 2012 |
| Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma JH Sampson, KD Aldape, GE Archer, A Coan, A Desjardins, AH Friedman, ... Neuro-oncology 13 (3), 324-333, 2011 | 389 | 2011 |
| Poor drug distribution as a possible explanation for the results of the PRECISE trial JH Sampson, G Archer, C Pedain, E Wembacher-Schröder, M Westphal, ... Journal of neurosurgery 113 (2), 301-309, 2010 | 282 | 2010 |
| Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer LW Jones, WE Hornsby, A Goetzinger, LM Forbes, EL Sherrard, M Quist, ... Lung cancer 76 (2), 248-252, 2012 | 251 | 2012 |
| Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial WE Hornsby, PS Douglas, MJ West, AA Kenjale, AR Lane, ER Schwitzer, ... Acta oncologica 53 (1), 65-74, 2014 | 212 | 2014 |
| Patients’ and parents’ needs, attitudes, and perceptions about early palliative care integration in pediatric oncology DR Levine, BN Mandrell, A Sykes, M Pritchard, D Gibson, HJ Symons, ... JAMA oncology 3 (9), 1214-1220, 2017 | 208 | 2017 |
| Bevacizumab and daily temozolomide for recurrent glioblastoma A Desjardins, DA Reardon, A Coan, J Marcello, JE Herndon, L Bailey, ... Cancer 118 (5), 1302-1312, 2012 | 196 | 2012 |
| Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non–small-cell lung carcinoma JK Hoang, LF Hoagland, RE Coleman, AD Coan, JE Herndon, EF Patz Jr Journal of Clinical Oncology 26 (9), 1459-1464, 2008 | 177 | 2008 |
| A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma JH Sampson, RJ Schmittling, GE Archer, KL Congdon, SK Nair, EA Reap, ... PloS one 7 (2), e31046, 2012 | 143 | 2012 |
| Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma E Ruden, DA Reardon, AD Coan, JE Herndon, WE Hornsby, M West, ... Journal of Clinical Oncology 29 (21), 2918-2923, 2011 | 134 | 2011 |
| Palliative care involvement is associated with less intensive end-of-life care in adolescent and young adult oncology patients JM Snaman, EC Kaye, JJ Lu, A Sykes, JN Baker Journal of palliative medicine 20 (5), 509-516, 2017 | 120 | 2017 |
| Adolescents' preferences for treatment decisional involvement during their cancer MS Weaver, JN Baker, JS Gattuso, DV Gibson, AD Sykes, PS Hinds Cancer 121 (24), 4416-4424, 2015 | 115 | 2015 |
| Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients AP Abernethy, SY Zafar, H Uronis, JL Wheeler, A Coan, K Rowe, ... Journal of pain and symptom management 40 (4), 545-558, 2010 | 106 | 2010 |
| Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma DA Reardon, AD Norden, A Desjardins, JJ Vredenburgh, JE Herndon, ... Journal of neuro-oncology 106, 409-415, 2012 | 103 | 2012 |
| Reducing compassion fatigue in inpatient pediatric oncology nurses CE Sullivan, BSN Amber-Rose King, BSN Joni Holdiness, ... Oncology nursing forum 46 (3), 338-347, 2019 | 101 | 2019 |
| Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy DA Reardon, A Desjardins, KB Peters, JJ Vredenburgh, S Gururangan, ... Cancer 117 (23), 5351-5358, 2011 | 99 | 2011 |
| Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients DA Reardon, JE Herndon, KB Peters, A Desjardins, A Coan, E Lou, ... British journal of cancer 107 (9), 1481-1487, 2012 | 94 | 2012 |
| Patterns of end-of-life care in children with advanced solid tumor malignancies enrolled on a palliative care service TZ Vern-Gross, CG Lam, Z Graff, S Singhal, DR Levine, D Gibson, ... Journal of pain and symptom management 50 (3), 305-312, 2015 | 91 | 2015 |
John H. Sampson, M.D., Ph.D., M.H.Sc...Wilkins Distinguished Professor and Chief of Neurosurgery在 duke.edu 的电子邮件经过验证
